4.7 Review

Harnessing the Potential of Non-Apoptotic Cell Death Processes in the Treatment of Drug-Resistant Melanoma

Related references

Note: Only part of the references are listed.
Article Chemistry, Multidisciplinary

A mitochondria-localized iridium(iii) photosensitizer for two-photon photodynamic immunotherapy against melanoma

Lili Wang et al.

Summary: Conventional photodynamic therapy mainly affects primary tumors, while complementary immunotherapy is effective in eliminating small, non-localized tumors. We report the development of a highly potent immunogenic cell death inducing photosensitizer, Ir-pbt-Bpa, for two-photon photodynamic immunotherapy against melanoma. Upon light irradiation, Ir-pbt-Bpa can induce cell death through a combination of ferroptosis and immunogenic cell death, leading to a strong reduction in tumor size.

CHEMICAL SCIENCE (2023)

Article Materials Science, Biomaterials

Boosting cancer immunotherapy by biomineralized nanovaccine with ferroptosis-inducing and photothermal properties

Siyu Ma et al.

Summary: This study proposed a therapeutic cancer nanovaccine that utilizes ferroptosis and photothermal effects to enhance cancer immunotherapy. The nanovaccine triggers immunogenic cell death and synergizes with exogenous antigens to boost the immune response. Combination with checkpoint blockade significantly enhances anti-cancer immunity and inhibits the growth of metastases.

BIOMATERIALS SCIENCE (2023)

Article Materials Science, Biomaterials

A self-assembling CXCR4-targeted pyroptosis nanotoxin for melanoma therapy

Zheng Zhao et al.

Summary: Immunotherapy is a promising strategy for melanoma treatment, but its efficacy is limited by the immunosuppressive tumor microenvironment. This study shows that a CXCR4 antagonist peptide can specifically target and internalize into CXCR4(+) melanoma cells. The researchers also developed a self-assembling nanotoxin that can target CXCR4-expression melanoma cells and induce tunable cellular pyroptosis. This nanotoxin enhances antitumor efficacy and minimizes systemic side effects in vivo. These findings provide new insights for engineering nanotoxins with tunable pyroptosis activity for biomedical applications.

BIOMATERIALS SCIENCE (2023)

Article Energy & Fuels

4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer

Wenchang Yang et al.

Summary: Cuproptosis, a new cell death pathway induced by copper, is associated with mitochondrial respiration and mediated by protein lipoylation. This study explores the role of cuproptosis in colorectal cancer progression. The results show that elesclomol-Cu inhibits cell viability and promotes apoptosis in colorectal cancer cells. Additionally, 4-Octyl itaconate (4-OI) enhances cuproptosis and inhibits aerobic glycolysis through GAPDH, leading to better anti-tumor effects in vivo.

ENERGY REPORTS (2023)

Article Biochemistry & Molecular Biology

Cuproptosis: p53-regulated metabolic cell death?

Chen Xiong et al.

Summary: Cuproptosis is a newly identified form of copper-induced cell death that primarily affects cells relying on oxidative phosphorylation as their main energy source. This process involves copper binding to lipoylated proteins in the tricarboxylic acid cycle, leading to the aggregation of these proteins, destabilization of iron-sulfur cluster proteins, and proteotoxic stress. Cancer cells, on the other hand, predominantly utilize glycolysis and are resistant to cuproptosis. However, the tumor suppressor p53, which regulates metabolism, may have a role in cuproptosis regulation by influencing glycolysis and the biogenesis of iron-sulfur clusters and the copper chelator glutathione.

CELL DEATH AND DIFFERENTIATION (2023)

Article Biophysics

DDTC-Cu(I) based metal-organic framework (MOF) for targeted melanoma therapy by inducing SLC7A11/GPX4-mediated ferroptosis

Chan Li et al.

Summary: In this study, a nanomedicine Cu-BTC@DDTC with high antitumor activity was prepared by loading diethyldithiocarbamate (DDTC) onto a nanoscale metal-organic framework (MOF) Cu-BTC. The results showed that Cu-BTC@DDTC had high drug loading and stability, and exhibited significant antitumor effect and biosafety. This study provides a feasible protocol for developing antitumor drugs based on the drug repurposing strategy.

COLLOIDS AND SURFACES B-BIOINTERFACES (2023)

Review Pharmacology & Pharmacy

Acquired non-thermal plasma resistance mediates a shift towards aerobic glycolysis and ferroptotic cell death in melanoma

Abraham Lin et al.

Summary: This study aimed to investigate the mechanisms of NTP therapy sensitivity and resistance by using the first-ever NTP-resistant cell line derived from sensitive melanoma cells. The cells were exposed to NTP for 12 weeks and evaluated against the parental control cells. Transcriptome sequencing and metabolic analysis revealed a preference towards aerobic glycolysis and increased vulnerability to lipid peroxidation and ferroptosis in NTP-resistant cells.

DRUG RESISTANCE UPDATES (2023)

Review Biochemistry & Molecular Biology

Cuproptosis: mechanisms and links with cancers

Jiaming Xie et al.

Summary: Cuproptosis is a unique form of copper-dependent cell death that is distinct from other known types of cell death. The debate on whether copper-induced cell death is an independent form of cell death or not has been settled with the discovery of the mechanism of cuproptosis, leading to increased interest in exploring the relationship between cuproptosis and cancer. This review provides a comprehensive overview of the systemic and cellular metabolic processes of copper, as well as the signaling pathways related to copper and tumors. Furthermore, it highlights the potential of using copper ion ionophores with cuproptosis-inducing functions in combination with small molecule drugs for targeted therapy in specific cancers.

MOLECULAR CANCER (2023)

Editorial Material Cell Biology

Deadly actin collapse by disulfidptosis

Laura M. Machesky

Summary: Programmed cell death (PCD) helps cells to benefit the surviving organism. A recent study shows that cells can program their death by inducing extensive disulfide bonding of the actin cytoskeleton in response to an imbalance of cystine, a raw material for glutathione production.

NATURE CELL BIOLOGY (2023)

Article Multidisciplinary Sciences

A cooperative nano-CRISPR scaffold potentiates immunotherapy via activation of tumour-intrinsic pyroptosis

Ning Wang et al.

Summary: Researchers use CRISPR-based nanotechnology to trigger immunologic cell death and achieve efficient anti-tumor immune response in mouse models of melanoma.

NATURE COMMUNICATIONS (2023)

Article Biochemistry & Molecular Biology

Inhibiting SCD expression by IGF1R during lorlatinib therapy sensitizes melanoma to ferroptosis

Furong Zeng et al.

Summary: Induction of ferroptosis is an emerging strategy to suppress melanoma progression. In this study, we found that lorlatinib, a drug targeting IGF1R, synergized with RSL3 to sensitize melanoma cells to ferroptosis. Lorlatinib achieved this by inhibiting the PI3K/AKT/mTOR signaling axis and its downstream SCD expression. Our results suggest that combination therapy with lorlatinib can greatly enhance the utility of GPX4 inhibition in melanoma patients with IGF1R-proficient expression.

REDOX BIOLOGY (2023)

Article Multidisciplinary Sciences

Systematic analysis of the aberrances and functional implications of cuproptosis in cancer

Jiangbing Li et al.

Summary: Cuproptosis, a form of cell death driven by copper-dependent proteo-toxic stress response, was comprehensively characterized across 33 cancers using multi-omic data from TCGA. The study revealed complex and diverse results in different cancers and investigated the relationships between cuproptosis-related genes (CRGs) and cancer metabolic patterns, pathway activity, and tumor microenvironment. The establishment of the cuproptosis potential index (CPI) further revealed the functional roles of cuproptosis and characterized its molecular features. The study also conducted a combined analysis of CRGs and CPI in drug response and immunotherapy.

ISCIENCE (2023)

Article Chemistry, Multidisciplinary

Bioengineering of BRAF and COX2 inhibitor nanogels to boost the immunotherapy of melanoma via pyroptosis

Meng-Jie Zhang et al.

Summary: Glutathione-responsive nanogels (CDNPs) crosslinked with crosslinker DBHD incorporating BRAF inhibitor dabrafenib and COX2 inhibitor celecoxib were synthesized. The CDNPs can efficiently induce tumor cell pyroptosis and activate strong antitumor immunity. Furthermore, CDNPs combined with alpha PD-1 antibody significantly suppressed tumor growth and prolonged survival in a melanoma mouse model.

CHEMICAL COMMUNICATIONS (2023)

Review Biochemistry & Molecular Biology

The Apoptosis Paradox in Cancer

Ornella Morana et al.

Summary: Cancer growth is characterized by an imbalance between cell gain and cell loss, with high-grade cancers often having high levels of apoptosis. While cell-autonomous apoptosis serves as a tumor suppressor mechanism, limited apoptosis can promote cell survival and resistance to therapy by conditioning the tumor microenvironment. Understanding the implications of cell death programs in tumor biology is crucial for cancer treatment.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Dermatology

Increased IRF9-STAT2 Signaling Leads to Adaptive Resistance toward Targeted Therapy in Melanoma by Restraining GSDME-Dependent Pyroptosis

Dan Wang et al.

Summary: This study identifies the increased expression of IRF9 and STAT2 in melanoma cells under BRAFis treatment and verifies their roles in resistance. Overexpression of IRF9 or STAT2 leads to decreased sensitivity to BRAFis treatment, while knockdown increases sensitivity. Further experiments show that IRF9-STAT2 signaling controls GSDME-dependent pyroptosis through restoring GSDME transcription. Targeting IRF9/STAT2 may provide a more effective treatment to prevent melanoma resistance to BRAFis.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Dermatology

Repurposing Melanoma Chemotherapy to Activate Inflammasomes in the Treatment of BRAF/MAPK Inhibitor Resistant Melanoma

Farzana Ahmed et al.

Summary: This study explores the resistance of melanoma to chemotherapy and suggests that melanoma with an inflammatory undifferentiated state may be susceptible to combination therapy. The study also investigates the variation in inflammasomes and death mechanisms in different melanoma, and raises the possibility of using the inflammatory state as biomarkers for inflammasome-targeted therapy.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Biochemistry & Molecular Biology

Targeting ErbB3 and Cellular NADPH/NADP+ Abundance Sensitizes Cutaneous Melanomas to Ferroptosis Inducers

Julia Leu et al.

Summary: This study reveals the association between elevated expression of ErbB3 and resistance to ferroptosis in melanoma. Knockdown of ErbB3 sensitizes melanomas to ferroptosis inducers and leads to a reduction in the cellular ratio of GSH/GSSG and NADPH/NADP+. The study also identifies small molecule inhibitors targeting ErbB3 signaling pathways that sensitize melanomas to ferroptosis activators, providing new insights into the regulation of this cell death process.

ACS CHEMICAL BIOLOGY (2022)

Article Engineering, Biomedical

Nano-enabled photosynthesis in tumours to activate lipid peroxidation for overcoming cancer resistances

Jun Jiang et al.

Summary: This study developed a tumor treatment method that can overcome melanoma resistance by activating cell death mechanisms through controlled photosynthesis. The experimental results showed that this treatment method can effectively inhibit the spread of melanoma and improve patients' survival rate.

BIOMATERIALS (2022)

Article Multidisciplinary Sciences

ADAR1 masks the cancer immunotherapeutic promise of ZBP1-driven necroptosis

Ting Zhang et al.

Summary: ADAR1 is a determinant of resistance to ICB therapy by repressing immunogenic dsRNA and Z-RNA. CBL0137 is a small molecule that activates ZBP1, reverses ICB unresponsiveness, and induced necroptosis.

NATURE (2022)

Article Pharmacology & Pharmacy

Phyto-sesquiterpene lactones DET and DETD-35 induce ferroptosis in vemurafenib sensitive and resistant melanoma via GPX4 inhibition and metabolic reprogramming

Meng-Ting Chang et al.

Summary: This study uncovers the abnormal upregulation of PUFAs and oxylipin metabolism in vemurafenib resistant melanoma cells. DET and DETD-35 induce cell death in sensitive and resistant BRAF(V600E) melanoma cells by reprogramming metabolism and causing mitochondrial damage, targeting GPX4 and ferroptosis.

PHARMACOLOGICAL RESEARCH (2022)

Article Multidisciplinary Sciences

AXL inhibition improves BRAF-targeted treatment in melanoma

Marta Nyakas et al.

Summary: This study investigated the therapeutic potential of combining an AXL inhibitor (AXLi) and a clinically relevant BRAF inhibitor (BRAFi) for the treatment of metastatic melanoma. The results showed that AXL was expressed in the majority of melanoma lymph node metastases. In vitro experiments demonstrated that the combination of AXLi and BRAFi resulted in the largest reduction in cell viability. Moreover, pre-clinical studies using AXL(high) melanoma models showed a therapeutic benefit of adding AXLi to the BRAF-targeted therapy. Mechanistic insights revealed that AXLi potentiated BRAFi-induced apoptosis, stimulated ferroptosis, and inhibited autophagy. Overall, this study suggests that combining AXLi with standard therapy could improve the therapeutic outcome in metastatic melanoma.

SCIENTIFIC REPORTS (2022)

Article Genetics & Heredity

Nobiletin Induces Ferroptosis in Human Skin Melanoma Cells Through the GSK3β-Mediated Keap1/Nrf2/HO-1 Signalling Pathway

Senling Feng et al.

Summary: Nobiletin, a natural product, induces ferroptosis in melanoma cells by regulating the GSK3β-mediated Keap1/Nrf2/HO-1 signaling pathway, demonstrating its potential as an anti-tumor agent.

FRONTIERS IN GENETICS (2022)

Review Pharmacology & Pharmacy

Non-apoptotic cell death-based cancer therapy: Molecular mechanism, pharmacological modulators, and nanomedicine

Xuan Wang et al.

Summary: Non-apoptotic cell death, such as ferroptosis, necroptosis, and pyroptosis, holds significant potential as an emerging cancer therapeutic target. Nanomedicine technology combined with different pathways and components can induce various forms of non-apoptotic cell death and achieve targeted and combination therapies.

ACTA PHARMACEUTICA SINICA B (2022)

Review Cell Biology

It's All in the PAN: Crosstalk, Plasticity, Redundancies, Switches, and Interconnectedness Encompassed by PANoptosis Underlying the Totality of Cell Death-Associated Biological Effects

Jessica M. Gullett et al.

Summary: The article discusses the cell death pathways and their interactions in the innate immune system. By viewing them through the lens of an integrated inflammatory cell death concept called PANoptosis, the diverse descriptions of interactions can be better understood. The article also introduces PANoptosomes as multifaceted macromolecular complexes regulating PANoptosis, and highlights the importance of PANoptosis in infections, diseases, and cancers. Having a holistic understanding of cell death is crucial for identifying new therapeutic strategies.

CELLS (2022)

Article Oncology

A Genome-Wide Screen Identifies PDPK1 as a Target to Enhance the Efficacy of MEK1/2 Inhibitors in NRAS Mutant Melanoma

Weijia Cai et al.

Summary: In this study, it was demonstrated that loss of phosphoinositide-dependent kinase-1 (PDPK1) enhances the efficacy of MEKi, and the synergistic effects of PDPK1 loss and MEKi were validated in NRAS mutant melanoma cell lines.

CANCER RESEARCH (2022)

Article Cell Biology

Targeting Wnt/beta-Catenin Signaling Exacerbates Ferroptosis and Increases the Efficacy of Melanoma Immunotherapy via the Regulation of MITF

Hao Wang et al.

Summary: This study found that Wnt/β-catenin signaling regulates ferroptosis in melanoma cells via the regulation of MITF, thus affecting the efficacy of immunotherapy. Targeting the Wnt/β-catenin-MITF pathway could be a promising strategy to enhance ferroptosis and increase the efficacy of anti-PD-1 immunotherapy.

CELLS (2022)

Article Oncology

Nanoparticle delivery of miR-21-3p sensitizes melanoma to anti-PD-1 immunotherapy by promoting ferroptosis

Weinan Guo et al.

Summary: The upregulation of miR-21-3p contributes to IFN-gamma-driven ferroptosis and synergizes with anti-PD-1 antibody. Nanoparticle delivery of miR-21-3p is a promising therapeutic approach to increase immunotherapy efficacy without obvious systemic side effects.

JOURNAL FOR IMMUNOTHERAPY OF CANCER (2022)

Article Cell Biology

Targeting of the Lipid Metabolism Impairs Resistance to BRAF Kinase Inhibitor in Melanoma

Elisabetta Vergani et al.

Summary: The study investigated the impact of lipid metabolism on melanoma sensitivity to BRAF inhibitors, revealing that targeting lipid metabolism pathways in resistant cells reduces cell growth, increases drug sensitivity, and induces the expression of enzymes involved in fatty acid and cholesterol metabolism.

FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2022)

Article Biochemistry & Molecular Biology

Cytoglobin Silencing Promotes Melanoma Malignancy but Sensitizes for Ferroptosis and Pyroptosis Therapy Response

Joey De Backer et al.

Summary: This study investigated the role of CYGB in melanoma cells. The findings suggest that CYGB knockdown increases the sensitivity of cells to ferroptosis and pyroptosis cell death signaling pathways, supporting a tumor-suppressive role for CYGB and its modulation of cancer therapy sensitivity.

ANTIOXIDANTS (2022)

Article Biochemistry & Molecular Biology

Ferroptosis Inducer Improves the Efficacy of Oncolytic Virus-Mediated Cancer Immunotherapy

Weilin Liu et al.

Summary: The study found that the combination of the ferroptosis activator Erastin with the oncolytic vaccinia virus could effectively inhibit tumor growth, prolong host survival, and enhance antitumoral immunity in hepatocellular carcinoma and colon cancer models.

BIOMEDICINES (2022)

Article Medicine, Research & Experimental

Gambogenic acid antagonizes the expression and effects of long non-coding RNA NEAT1 and triggers autophagy and ferroptosis in melanoma

Meng Wang et al.

Summary: This study identified the upregulation of NEAT1 in melanoma, which is closely related to cell proliferation. Downregulation of NEAT1 can suppress ferroptosis and autophagy in melanoma cells. Additionally, GNA treatment decreases the levels of NEAT1 and inhibits melanoma cell proliferation.

BIOMEDICINE & PHARMACOTHERAPY (2022)

Article Oncology

Raptinal Induces Gasdermin E-Dependent Pyroptosis in Naive and Therapy-Resistant Melanoma

Megane Vernon et al.

Summary: The caspase-3 activator raptinal can induce pyroptosis in melanoma cells and delay tumor growth. The release of damage-associated molecular patterns and inflammatory cytokines depends on caspase activity and GSDME expression. Furthermore, raptinal can stimulate pyroptosis in melanoma models resistant to BRAF and MEK inhibitors.

MOLECULAR CANCER RESEARCH (2022)

Article Biochemistry & Molecular Biology

Integrated regulation of stress responses, autophagy and survival by altered intracellular iron stores

Yunyang Wang et al.

Summary: Iron excess and deficiency can cause cellular stress and death through the common mechanism of impaired autophagic function.

REDOX BIOLOGY (2022)

Article Biology

Pyroptosis correlates with tumor immunity and prognosis

Xiaoying Lou et al.

Summary: A pan-cancer analysis reveals the importance of pyroptosis in tumor development, prognosis, and immunotherapy. Pyroptosis is associated with tumor immunity, as evident from the elevated expression of pyroptosis-associated genes in high-immune-activity tumors. Furthermore, pyroptosis directly influences the expression of immune checkpoint molecules and cytokines. Pyroptosis score can serve as a potential independent prognostic indicator and help predict the effectiveness of anti-PD-1 immunotherapy.

COMMUNICATIONS BIOLOGY (2022)

Review Biochemistry & Molecular Biology

Copper homeostasis and cuproptosis in health and disease

Liyun Chen et al.

Summary: Copper is an essential micronutrient that is required for various physiological processes in almost all cell types, and its homeostasis is tightly regulated to avoid oxidative stress and cellular dysfunction. Recent studies have identified a novel form of cell death called cuproptosis, which is induced by copper binding to lipoylated enzymes in the tricarboxylic acid cycle and ultimately leads to protein aggregation, proteotoxic stress, and cell death. This article summarizes current knowledge on copper metabolism, copper-related diseases, the characteristics of cuproptosis, and the regulatory mechanisms involved. The implications of cuproptosis in the pathogenesis of diseases such as Wilson's disease, neurodegenerative diseases, and cancer are also discussed, along with the therapeutic potential of targeting cuproptosis.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Review Biochemistry & Molecular Biology

Autophagy, ferroptosis, pyroptosis, and necroptosis in tumor immunotherapy

Weitong Gao et al.

Summary: Immunotherapy has made significant breakthroughs in cancer treatment, but the poor response of some tumors limits its application. Inducing non-apoptotic regulated cell death (RCD) may convert these unresponsive tumors into those that respond to immunotherapy. Autophagy, ferroptosis, pyroptosis, and necroptosis have been found to have both inhibitory and synergistic effects on antitumor immune responses, suggesting that targeted therapies against these processes combined with immunotherapy may be effective even in resistant tumors.

SIGNAL TRANSDUCTION AND TARGETED THERAPY (2022)

Article Medicine, Research & Experimental

IL-9/STAT3/fatty acid oxidation-mediated lipid peroxidation contributes to Tc9 cell longevity and enhanced antitumor activity

Liuling Xiao et al.

Summary: This study reveals that lipid peroxidation regulates the longevity and antitumor effects of Tc9 cells through the IL-9/STAT3/fatty acid oxidation pathway. Modulating T cell lipid peroxidation can be utilized to enhance T cell-based immunotherapy in human cancer.

JOURNAL OF CLINICAL INVESTIGATION (2022)

Article Biochemistry & Molecular Biology

The alkaloid, soyauxinium chloride, displays remarkable cytotoxic effects towards a panel of cancer cells, inducing apoptosis, ferroptosis and necroptosis

Armelle T. Mbaveng et al.

Summary: The cytotoxic potential of the naturally occurring indoloquinazoline alkaloid SCHL was evaluated on a broad panel of animal and human cancer cell lines. SCHL exhibited cytotoxic effects against various cancer cell lines and induced apoptosis, ferroptosis, and necroptosis. Further research on SCHL may lead to the development of a novel drug for combating cancers, including refractory phenotypes.

CHEMICO-BIOLOGICAL INTERACTIONS (2021)

Article Surgery

Melanoma Risk Factors and Prevention

William W. Dzwierzynski

CLINICS IN PLASTIC SURGERY (2021)

Article Oncology

The Lipogenic Regulator SREBP2 Induces Transferrin in Circulating Melanoma Cells and Suppresses Ferroptosis

Xin Hong et al.

Summary: Circulating tumor cells shed by cancer into the bloodstream coordinately upregulate lipogenesis and iron homeostasis pathways, contributing to resistance to BRAF inhibitors. The lipogenesis regulator SREBP2 induces transcription of iron carrier TF, reducing oxidative stress and conferring resistance to ferroptosis inducers. Presence of CTCs with high lipogenic and iron metabolic signatures is correlated with adverse clinical outcome in melanoma patients.

CANCER DISCOVERY (2021)

Article Oncology

Pharmacologic Screening Identifies Metabolic Vulnerabilities of CD8+ T Cells

Jefte M. Drijvers et al.

Summary: Metabolic vulnerabilities of CD8(+) T cells and cancer cells were identified through a high-throughput in vitro pharmacologic screening platform, with CD8(+) T cells found to be more sensitive to ferroptosis induction. The screening platform may also be useful for rapid testing of compounds targeting antitumor CD8(+) T-cell function and potential therapeutic targets.

CANCER IMMUNOLOGY RESEARCH (2021)

Article Chemistry, Medicinal

A Novel Anticancer Stem Cell Compound Derived from Pleuromutilin Induced Necroptosis of Melanoma Cells

Kun Zhang et al.

Summary: This study introduces a novel Pleuromutilin derivative, compound 38, which induces necroptosis in melanoma cancer cells and demonstrates promising anti-tumor effects in animal models. This compound also shows low toxicity and excellent pharmacokinetic properties, making it a potential candidate for anticancer drug development.

JOURNAL OF MEDICINAL CHEMISTRY (2021)

Article Cell Biology

CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability

Xingzhe Ma et al.

Summary: Understanding the mechanisms of how T cells become dysfunctional in a tumor microenvironment is crucial for cancer immunotherapy. This study found that CD36 expression in tumor-infiltrating CD8(+) T cells, induced by TME cholesterol, is associated with tumor progression and poor survival, and that genetic ablation of Cd36 in these T cells leads to enhanced tumor eradication. Targeting CD36 or inhibiting ferroptosis could restore T cell function and enhance antitumor efficacy, especially in combination with anti-PD-1 antibodies.

CELL METABOLISM (2021)

Article Multidisciplinary Sciences

A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis

Guohao Wang et al.

Summary: This study reveals the ability of exosomal PD-L1 to inhibit T cell activity and confer resistance to immune checkpoint blockade therapy. By combining an exosome inhibitor and a ferroptosis inducer in a nanotherapy, the response to anti-tumor immune responses is enhanced, particularly in the context of PD-L1 checkpoint blockade.

NATURE COMMUNICATIONS (2021)

Article Cell Biology

ADAR1 restricts ZBP1-mediated immune response and PANoptosis to promote tumorigenesis

Rajendra Karki et al.

Summary: The study uncovers the role of ADAR1 in suppressing ZBP1-mediated PANoptosis and promoting tumorigenesis. Additionally, the use of IFN-gamma and NEI KPT-330 regresses melanoma in a ZBP1-dependent manner, providing important insights for cancer therapeutic strategies.

CELL REPORTS (2021)

Review Biochemistry & Molecular Biology

The Chemistry of Reactive Oxygen Species (ROS) Revisited: Outlining Their Role in Biological Macromolecules (DNA, Lipids and Proteins) and Induced Pathologies

Celia Andres Juan et al.

Summary: Living species are constantly exposed to oxidants, leading to oxidative stress and disease. The induction of oxidative stress is caused by an imbalance between radical species and antioxidant defense systems, which can damage cellular biomolecules.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Medicine, Research & Experimental

T cell-derived tumor necrosis factor induces cytotoxicity by activating RIPK1-dependent target cell death

Nicholas Chun et al.

Summary: The research indicates that TNF released by T cells can activate RIPK1-dependent cell death program in target cells, leading to target cell lysis. This phenomenon not only accelerates murine cardiac allograft rejection but also synergizes with anti-PD1 administration to destroy checkpoint blockade-resistant murine melanoma.

JCI INSIGHT (2021)

Article Engineering, Biomedical

Engineered exosome-like nanovesicles suppress tumor growth by reprogramming tumor microenvironment and promoting tumor ferroptosis

Shichuan Hu et al.

Summary: In this study, fibroblast activation protein-alpha (FAP) gene-engineered tumor cell-derived exosome-like vesicle vaccines (eNVs-FAP) were developed as a candidate tumor vaccine targeting both the tumor parenchyma and the stroma. The eNVs-FAP vaccine showed excellent antitumor effects by inducing strong and specific CTL immune responses against tumor cells and FAP +CAFs, and reprogramming the immunosuppressive TME in various cancer models. The mechanistic analysis revealed that eNVs-FAP promoted DC maturation, increased effector T cell infiltration, and reduced immunosuppressive cell populations in the TME, leading to enhanced tumor cell ferroptosis.

ACTA BIOMATERIALIA (2021)

Article Chemistry, Multidisciplinary

Acidity-Activatable Dynamic Nanoparticles Boosting Ferroptotic Cell Death for Immunotherapy of Cancer

Rundi Song et al.

Summary: Researchers have developed a immunotherapy method that enhances the immunogenicity of tumor cells by inducing ferroptosis, thereby improving the efficacy of cancer immunotherapy.

ADVANCED MATERIALS (2021)

Article Oncology

Iron regulatory protein 1 promotes ferroptosis by sustaining cellular iron homeostasis in melanoma

Fengping Yao et al.

Summary: Iron regulatory protein IRP1 plays an essential role in ferroptosis induced by erastin and RSL3, regulating iron homeostasis and affecting the survival and death of melanoma cells.

ONCOLOGY LETTERS (2021)

Article Cell Biology

Suppressive role of microRNA-130b-3p in ferroptosis in melanoma cells correlates with DKK1 inhibition and Nrf2-HO-1 pathway activation

Yangying Liao et al.

Summary: miR-130b-3p inhibits ferroptosis in melanoma cells by activating the Nrf2/HO-1 pathway through suppression of DKK1, highlighting its potential as a therapeutic target for melanoma treatment.

HUMAN CELL (2021)

Article Cell Biology

The glutathione peroxidase Gpx4 prevents lipid peroxidation and ferroptosis to sustain Treg cell activation and suppression of antitumor immunity

Chengxian Xu et al.

Summary: Research shows that Gpx4 plays a crucial role in protecting Treg cells from lipid peroxidation and ferroptosis, regulating immune homeostasis and antitumor immunity. Deletion of Gpx4 can lead to lipid peroxidation and ferroptosis of Treg cells, affecting immune homeostasis and antitumor immunity. Neutralization of lipid peroxides and blockade of iron availability rescue ferroptosis of Gpx4-deficient Treg cells.

CELL REPORTS (2021)

Article Chemistry, Multidisciplinary

Light-Activated Protoporphyrin IX-Based Polysilsesquioxane Nanoparticles Induce Ferroptosis in Melanoma Cells

Hemapriyadarshini Vadarevu et al.

Summary: The use of nanoparticle-based materials in photodynamic therapy for cancer treatment is a growing area of research, with Polysilsesquioxane nanoparticles showing promise in enhancing PDT effectiveness. This study focused on a Protroporphyrin IX-based PSilQ platform, revealing that cell death pathways during PDT were regulated by both apoptosis and ferroptosis.

NANOMATERIALS (2021)

Review Oncology

Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance

Christiana M. Neophytou et al.

Summary: This review discusses the deregulation of apoptotic pathways as a key factor leading to multidrug resistance (MDR) in cancer cells, along with the impact of the tumor microenvironment on apoptosis in MDR tumors. Therapeutic approaches targeting Bcl-2 family members, IAPs, and AKT, as well as the potential of epigenetic modifications in reversing MDR, are highlighted as important strategies against drug resistance.

CANCERS (2021)

Article Oncology

Pyroptosis-Related Gene Signatures Can Robustly Diagnose Skin Cutaneous Melanoma and Predict the Prognosis

Anji Ju et al.

Summary: The study found that pyroptosis-related genes play an important role in the diagnosis and prognosis of skin cutaneous melanoma (SKCM), with the ability to construct effective diagnostic classifiers and prognostic models, closely related to immune response.

FRONTIERS IN ONCOLOGY (2021)

Article Oncology

Combined Anticancer Effect of Plasma-Activated Infusion and Salinomycin by Targeting Autophagy and Mitochondrial Morphology

Takashi Ando et al.

Summary: PAI is a novel NTAPP-based anticancer agent that kills malignant cells, especially when used in combination with Sal. The combined administration of PAI and Sal is more effective in reducing tumor growth and metastasis, with minimal adverse effects.

FRONTIERS IN ONCOLOGY (2021)

Review Medicine, General & Internal

Advances in Prevention and Surveillance of Cutaneous Malignancies

Megan H. Trager et al.

AMERICAN JOURNAL OF MEDICINE (2020)

Article Multidisciplinary Sciences

Nedd4 ubiquitylates VDAC2/3 to suppress erastin-induced ferroptosis in melanoma

Yongfei Yang et al.

NATURE COMMUNICATIONS (2020)

Review Oncology

Targeting apoptosis in cancer therapy

Benedito A. Carneiro et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2020)

Review Dermatology

RIPK1: A rising star in inflammatory and neoplastic skin diseases

Liping Jin et al.

JOURNAL OF DERMATOLOGICAL SCIENCE (2020)

Article Pharmacology & Pharmacy

Gambogenic acid induces ferroptosis in melanoma cells undergoing epithelial-to-mesenchymal transition

Meng Wang et al.

TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)

Article Biochemistry & Molecular Biology

TAK1 regulates endothelial cell necroptosis and tumor metastasis

Lida Yang et al.

CELL DEATH AND DIFFERENTIATION (2019)

Article Biochemistry & Molecular Biology

TAK1 suppresses RIPK1-dependent cell death and is associated with disease progression in melanoma

Biswajit Podder et al.

CELL DEATH AND DIFFERENTIATION (2019)

Review Oncology

Ferroptosis, a new form of cell death: opportunities and challenges in cancer

Yanhua Mou et al.

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Review Cell Biology

Cell death: a review of the major forms of apoptosis, necrosis and autophagy

Mark S. D'Arcy

CELL BIOLOGY INTERNATIONAL (2019)

Article Multidisciplinary Sciences

CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy

Weimin Wang et al.

NATURE (2019)

Article Biochemistry & Molecular Biology

Delivery of Mixed-Lineage Kinase Domain-Like Protein by Vapor Nanobubble Photoporation Induces Necroptotic-Like Cell Death in Tumor Cells

Lien Van Hoecke et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)

Article Cell Biology

Aldo-keto reductases protect metastatic melanoma from ER stress-independent ferroptosis

Mara Gagliardi et al.

CELL DEATH & DISEASE (2019)

Article Biochemistry & Molecular Biology

miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma

Meiying Luo et al.

CELL DEATH AND DIFFERENTIATION (2018)

Article Biochemistry & Molecular Biology

miR-9 regulates ferroptosis by targeting glutamic-oxaloacetic transaminase GOT1 in melanoma

Kexin Zhang et al.

MOLECULAR CARCINOGENESIS (2018)

Article Biochemistry & Molecular Biology

A Novel Naphthyridine Derivative, 3u, Induces Necroptosis at Low Concentrations and Apoptosis at High Concentrations in Human Melanoma A375 Cells

Qinghong Kong et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2018)

Article Oncology

Molecular Pathways: The Necrosome-A Target for Cancer Therapy

Lena Seifert et al.

CLINICAL CANCER RESEARCH (2017)

Article Multidisciplinary Sciences

Dependency of a therapy-resistant state of cancer cells on a lipid peroxidase pathway

Vasanthi S. Viswanathan et al.

NATURE (2017)

Article Cell Biology

Autophagy promotes ferroptosis by degradation of ferritin

Wen Hou et al.

AUTOPHAGY (2016)

Article Nanoscience & Nanotechnology

Ultrasmall nanoparticles induce ferroptosis in nutrient-deprived cancer cells and suppress tumour growth

Sung Eun Kim et al.

NATURE NANOTECHNOLOGY (2016)

Article Cell Biology

Absence of RIPK3 predicts necroptosis resistance in malignant melanoma

P. Geserick et al.

CELL DEATH & DISEASE (2015)

Article Biochemistry & Molecular Biology

Regulation of Ferroptotic Cancer Cell Death by GPX4

Wan Seok Yang et al.

Article Medicine, General & Internal

Cutaneous melanoma

Alexander M. M. Eggermont et al.

LANCET (2014)

Article Biochemistry & Molecular Biology

Necroptosis modulated by autophagy is a predominant form of melanoma cell death induced by sanguilutine

Jindriska Hammerova et al.

BIOLOGICAL CHEMISTRY (2012)

Article Multidisciplinary Sciences

The copper transporter CTR1 provides an essential function in mammalian embryonic development

YM Kuo et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)